DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/n8484d/cns_drug_news) has announced the addition of the "CNS Drug News Issue" newsletter to their offering. Generic competition for the 20mg version of Teva Pharmaceutical Industries current multiple sclerosis market leader Copaxone will be available in the US by September. About Altace (Ramipril) with no Rx This, coupled with growing sales of Biogen s Tecfidera, will see Tecfidera 2015 sales overtake those of Copaxone. These days we all suffer from information overload; by focusing specifically on CNS drugs, the CNS Drug News online service will deliver the information you need in a timely, flexible and convenient format. An ageing population and ever better rates of diagnosis is seeing the incidence of major CNS sectors rise considerably - particularly demanding are the neurodegenerative conditions. Buy Xylocaine (Lidocaine) with free Rx Even so, levels of unmet clinical need remain high and growth is expected to continue. For pharmaceutical company executives, researchers and commercial managers, staying in touch with the latest twists and turns is another matter. Buy Levitra Pack-90 () without Rx That is why CNS Drug News is essential. The CNS Drug News service provides unbeatable coverage: - The full text daily of the latest news reported on all types of CNS drugs for leading CNS conditions - An easy-to-use interface that immediately takes you to the most recently-updated information - An extensive archive of articles, which makes the service a valuable tracking and research tool - A fast and effective search facility allowing you to identify information relevant to you - Daily or weekly email alerts that will ensure you know when new information is added - An RSS feed facility Every day, the researchers and editors - Track the companies and research organisations that are shaping the industry - Monitor results from major conferences and meetings Report the latest developments in current and up-coming CNS drugs, including those for: - Neurodegenerative Disorders - Sleep Disorders - Depression - Psychotic Disorders - Analgesia/Anaesthetics - Epilepsy - Substance Dependence Therapies - Nausea & Vertigo - Cerebrovascular Disorders - Eating Disorders Key Topics Covered: 1. About Flutinap with no Rx Tecfidera Will Be Leading MS Drug In 2015 2. Buy Imodium (Loperamide) with free prescription Neurodegenerative Disorders 3. Buy Cough online Parkinson s Disease - R&D 4. http://cholesterolreviews.wordpress.com Biotie Provides Update On Tozadenant Phase III Programme 5. R&D 6. R&D 7. GW Receives FDA ODD For CBD For NHIE 8. R&D 9. Follow-Up Announcement Made On Preliminary Findings From Lurasidone Phase III Study 10. Product Updates 11. R&D 12. Product Updates For more information visit .researchandmarkets.com/research/n8484d/cns_drug_news About Research and Markets Research and Markets is the world s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.